Back to today’s briefing

Story perspectives

Multi-Cancer Blood Tests Fail to Cut Advanced Cancer Diagnoses

4/22/2026

27 6 Full Breakdown

Summary

Story summary

Multi-cancer blood tests like the Galleri test aim to detect various cancers early.
The largest trial did not significantly reduce diagnoses of advanced cancers.
Dr. Aadel Chaudhuri says more data are needed to assess whether these tests save lives.
Dr. Deb Schrag says demonstrating a decrease in stage 4 cancers is crucial for medical acceptance.
These tests lack FDA approval and are mainly available through high-end clinics.

1 of 1

Story summary

Multi-cancer blood tests like the Galleri test aim to detect various cancers early.
The largest trial did not significantly reduce diagnoses of advanced cancers.
Dr. Aadel Chaudhuri says more data are needed to assess whether these tests save lives.
Dr. Deb Schrag says demonstrating a decrease in stage 4 cancers is crucial for medical acceptance.
These tests lack FDA approval and are mainly available through high-end clinics.